The BCW Index rose .6 percent for the five-day trading period ended Tuesday. Though only a slight gain, it performed better than the Dow Jones Industrial Average, Nasdaq, and Nasdaq Biotech Index which fell .1 percent, .8 percent, and 1.4 percent, respectively.
 
PerkinElmer led gainers with a 3.5 percent rise, followed by Qiagen, which climbed 3.2 percent, and Bio-Rad, which closed up 3 percent. Millipore had the sharpest drop, finishing the tracking period down 1.6 percent.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.